VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AGO
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AGOAssured Guaranty Ltd.
$80.19$3.6B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAGOQuarterly Financials

Assured Guaranty Ltd. (AGO) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Assured Guaranty Ltd. (AGO) quarterly income statement — complete revenue, gross profit & net income history

AGO Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue261M213M199M278M325M152M252M194M226M282M154M357M230M305M22M77M280M184M191M167M
Revenue Growth %-19.69%40.13%-21.03%43.3%43.81%-46.1%63.64%-45.66%-1.74%-7.54%600%363.64%-17.86%65.76%-88.48%-53.89%79.49%-51.19%-23.6%-51.03%
Medical Costs & Claims24M18M-24M33M45M34M-46M1M5M6M104M58M7M48M-71M-8M61M-162M-65M-12M
Medical Cost Ratio %9.2%8.45%-12.06%11.87%13.85%22.37%-18.25%0.52%2.21%2.13%67.53%16.25%3.04%15.74%-322.73%-10.39%21.79%-88.04%-34.03%-7.19%
Gross Profit237M195M223M245M280M118M298M193M221M276M50M299M223M257M93M85M219M346M256M179M
Gross Margin %90.8%91.55%112.06%88.13%86.15%77.63%118.25%99.48%97.79%97.87%32.47%83.75%96.96%84.26%422.73%110.39%78.21%188.04%134.03%107.19%
Gross Profit Growth %-15.36%65.25%-25.17%26.94%26.7%-57.25%496%-35.45%-0.9%7.39%-46.24%251.76%1.83%-25.72%-63.67%-52.51%78.05%15.72%47.98%-40.33%
Operating Expenses203M30M88M112M51M88M78M99M77M74M-152M155M103M158M115M107M126M14M251M54M
OpEx / Revenue %77.78%14.08%44.22%40.29%15.69%57.89%30.95%51.03%34.07%26.24%-98.7%43.42%44.78%51.8%522.73%138.96%45%7.61%131.41%32.34%
Depreciation & Amortization00000000000000000000
Combined Ratio %86.97%22.54%32.16%52.16%29.54%80.26%12.7%51.55%36.28%28.37%-31.17%59.66%47.83%67.54%200%128.57%66.79%-80.43%97.38%25.15%
Operating Income34M165M135M133M229M30M220M94M144M202M202M144M120M99M-22M-22M93M332M5M125M
Operating Margin %13.03%77.46%67.84%47.84%70.46%19.74%87.3%48.45%63.72%71.63%131.17%40.34%52.17%32.46%-100%-28.57%33.21%180.43%2.62%74.85%
Operating Income Growth %-85.15%450%-38.64%41.49%59.03%-85.15%8.91%-34.72%20%104.04%1018.18%754.55%29.03%-70.18%-540%-117.6%520%90.8%-93.67%-43.69%
EBITDA34M187M157M156M251M53M242M117M167M225M226M166M141M120M-2M-2M113M352M28M148M
EBITDA Margin %13.03%87.79%78.89%56.12%77.23%34.87%96.03%60.31%73.89%79.79%146.75%46.5%61.3%39.34%-9.09%-2.6%40.36%191.3%14.66%88.62%
Interest Expense22M22M22M23M22M23M22M23M23M23M24M22M21M21M20M20M20M20M23M23M
Non-Operating Income0-22M-22M-23M-22M-23M-22M-23M-23M-23M-24M-22M-21M-21M-20M-20M-20M-20M-23M-23M
Pretax Income65M165M135M133M229M30M220M94M144M202M202M144M120M99M-22M-22M93M332M5M125M
Pretax Margin %24.9%77.46%67.84%47.84%70.46%19.74%87.3%48.45%63.72%71.63%131.17%40.34%52.17%32.46%-100%-28.57%33.21%180.43%2.62%74.85%
Income Tax-20M27M21M27M44M8M44M13M31M-177M43M18M23M17M-27M3M18M50M-15M23M
Effective Tax Rate %-30.77%16.36%15.56%20.3%19.21%26.67%20%13.83%21.53%-87.62%21.29%12.5%19.17%17.17%122.73%-13.64%19.35%15.06%-300%18.4%
Net Income88M119M105M103M176M18M171M78M109M376M157M125M81M94M11M-47M66M263M17M98M
Net Margin %33.72%55.87%52.76%37.05%54.15%11.84%67.86%40.21%48.23%133.33%101.95%35.01%35.22%30.82%50%-61.04%23.57%142.93%8.9%58.68%
Net Income Growth %-50%561.11%-38.6%32.05%61.47%-95.21%8.92%-37.6%34.57%300%1327.27%365.96%22.73%-64.26%-35.29%-147.96%500%77.7%-80.23%-46.45%
EPS (Diluted)1.912.412.112.083.440.353.171.421.896.452.602.081.341.520.08-0.390.983.740.221.29
EPS Growth %-44.48%588.57%-33.44%46.48%82.01%-94.57%21.92%-31.73%41.04%324.34%3170.44%633.33%36.73%-59.36%-63.86%-130.23%600%95.81%-78.43%-38.57%
EPS (Basic)1.912.432.132.103.490.363.231.441.946.602.652.111.371.560.08-0.391.003.900.221.31
Diluted Shares Outstanding45.4M49.4M49.4M49.4M50.7M51.9M53.4M55M57.1M58.3M59.6M60.1M60.4M61M62.9M63.8M67.4M70.4M73.6M76M